Analysts have been eager to weigh in on the Healthcare sector with new ratings on Intuitive Surgical (ISRG) and Teva Pharmaceutical Industries (TEVA).
Intuitive Surgical (ISRG)
In a report issued on December 6, Larry Biegelsen from Wells Fargo maintained a Buy rating on Intuitive Surgical. The company’s shares closed last Monday at $585.57, close to its 52-week high of $594.17.
According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 15.1% and a 69.4% success rate. Biegelsen covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Edwards Lifesciences.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Intuitive Surgical with a $618.00 average price target.
See today’s analyst top recommended stocks >>
Teva Pharmaceutical Industries (TEVA)
Wells Fargo analyst David Maris maintained a Hold rating on Teva Pharmaceutical Industries on December 6. The company’s shares closed last Monday at $9.92.
According to TipRanks.com, Maris is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -6.3% and a 37.2% success rate. Maris covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Bausch Health Companies, and Emergent Biosolutions.
Currently, the analyst consensus on Teva Pharmaceutical Industries is a Hold with an average price target of $8.78.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.